DOX and CpG release via MMP-9 enzyme in TME could increase tumor-specific antigen (TSA) releasing and recruitment of CD8 + and CD4 + T cells to both tumor environments and spleen, repressing tumor development, and improving animal survival (Fig. 14B). The gene discussed is CD8A; the disease is neoplasm.